DUBLIN, Calif., Nov. 13 /PRNewswire-FirstCall/ -- SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the Lazard Capital Markets Fifth Annual Healthcare Conference on Tuesday, November 18, 2008 at the St. Regis in New York, New York.
SuperGen’s presentation at the Lazard Capital Markets Fifth Annual Healthcare Conference is scheduled to begin at 4:40 p.m. EDT (1:40 p.m. PDT). A live webcast of the presentation will be available on the investor relations section of the Company’s Web site at www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit www.supergen.com.
CONTACT: Timothy L. Enns, SVP, Corporate Communications & Business
Development of SuperGen, Inc., +1-925-560-2810, tenns@supergen.com; or
Media, Michael Beckerich of Dorland Global Public Relations,
+1-212-677-7632, mbeckerich@dorland.com, for SuperGen, Inc.
Web site: http://www.supergen.com/
